Supportive care in hematological malignancies: hematopoietic growth factors, infections, transfusion therapy.
This article focuses on a selected number of topics among recent developments in the supportive care of hematological malignancies. The first section focuses on the role of hematopoietic growth factors, such as granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, thrombopoietin, interleukin-11, and keratinocyte growth factor. The following sections discuss the management of fungal and viral infections as well as changes in the current policies of platelet transfusion. The focus of this review is on the clinical utility and economic feasibility of the published findings.
Department of Internal Medicine, Freiburg University Medical Center, Freiburg im Breisgau, Germany.
S
S
Fetscher
R
R
Mertelsmann
D000890:Anti-Infective Agents / Q000627:therapeutic use; D003141:Communicable Diseases / Q000150:complications / Q000188:drug therapy; D019337:Hematologic Neoplasms / Q000150:complications / Q000628:therapy*; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use; D006801:Humans; D008020:Life Support Care; D017713:Platelet Transfusion
D000890:Anti-Infective Agents; D016298:Hematopoietic Cell Growth Factors